| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |